Brevan Howard Capital Management LP Atri Cure, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 8,041 shares of ATRC stock, worth $263,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,041
Previous 9,864
18.48%
Holding current value
$263,262
Previous $301,000
13.95%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$154 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$151 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$120 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$98.2 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$79.8 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.52B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...